Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001724521-25-000088
Filing Date
2025-06-12
Accepted
2025-06-12 16:28:21
Documents
2
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749760091.html 4  
1 FORM 4 wk-form4_1749760091.xml 4 5612
2 EX-24.1 section16and144poa-lacey.htm EX-24.1 10428
  Complete submission text file 0001724521-25-000088.txt   17423
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Issuer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Lacey David L. (Reporting) CIK: 0001734422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38419 | Film No.: 251043156